KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Liabilities and Shareholders Equity (2016 - 2025)

West Pharmaceutical Services' Liabilities and Shareholders Equity history spans 17 years, with the latest figure at $4.1 billion for Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity rose 11.72% year-over-year to $4.1 billion; the TTM value through Dec 2025 reached $11.7 billion, down 18.97%, while the annual FY2024 figure was $3.6 billion, 4.86% down from the prior year.
  • Liabilities and Shareholders Equity for Q3 2025 was $4.1 billion at West Pharmaceutical Services, up from $4.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $4.1 billion in Q3 2025 and bottomed at $2.7 billion in Q1 2021.
  • The 5-year median for Liabilities and Shareholders Equity is $3.6 billion (2022), against an average of $3.5 billion.
  • The largest annual shift saw Liabilities and Shareholders Equity grew 22.62% in 2021 before it fell 4.91% in 2024.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $3.3 billion in 2021, then increased by 9.14% to $3.6 billion in 2022, then grew by 5.88% to $3.8 billion in 2023, then dropped by 4.86% to $3.6 billion in 2024, then grew by 12.69% to $4.1 billion in 2025.
  • Per Business Quant, the three most recent readings for WST's Liabilities and Shareholders Equity are $4.1 billion (Q3 2025), $4.0 billion (Q2 2025), and $3.6 billion (Q1 2025).